The Conversation

The Conversation provides a platform for researchers of all disciplines to write about research developments for a public audience.  They have a wide range of articles on coronavirus that provide insight into the work being carried out.  You can find articles on many aspects of coronavirus research on their website.

Professor Sheena Cruickshank fro the UK-CIC Advisory Board has written some articles on immunology of COVID-19 for The Conversation, linked to below.

11 January 2021
COVID-19 immunity: how long does it last?
Observational studies give real hope for the durability and potential of protective immunity.
Written by Professor Sheena Cruickshank from UK-CIC Advisory Board

27 October 2020
A new study suggests coronavirus antibodies fade over time - but how concerned should we be?
Antibody levels fade naturally - the key question is whether infected people sustain adequate levels of B cells and T cells.
Written by Professor Sheena Cruickshank from UK-CIC Advisory Board

16 October 2020
Coronavirus reinfection cases: what we know so far – and the vital missing clues
Reports of reinfection shouldn't be cause for alarm. If we gather the right data, they can teach us a lot about the immune response.
Written by Professor Sheena Cruickshank from UK-CIC Advisory Board

26 August 2020
Inflammation: the key factor that explains vulnerability to severe COVID
Abnormal functioning of the immune system is what characterises severe COVID, and can be driven by diabetes, obesity, sex and age.
Written by Professor Sheena Cruickshank from the UK-CIC Advisory Board

10 July 2020
One vaccine to beat COVID, Sars, Mers and common cold – possible?
Some viruses are similar enough that just one vaccine is needed to treat them all.
Written by Professor Sheena Cruickshank from the UK-CIC Advisory Board

11 June 2020
Coronavirus: how T cells are involved and what it might mean for vaccine development
Just focusing on spike proteins might not offer the complete immunity.
Written by Professor Sheena Cruickshank from the UK-CIC Advisory Board and Professor Dan Davis from University of Manchester